The Baltimore Sun has started a new health story on situation in Iraq. In its first of a three-part series, titled Dangerous remedy, it highlighted that military doctors in Iraq say that Factor VII saves wounded soldiers, but other doctors and medical research suggest that it can cause fatal clots.
Results of a new analysis showed that patients who have heart disease and chronic kidney disease who took Lipitor? (atorvastatin calcium) Tablets (80 mg) reduced their risk of heart attack and stroke by 32 percent compared with patients taking the 10 mg dose of Lipitor. This analysis of a subset of patients from the five-year TNT (Treating to New Targets) study was designed and completed after the end of the trial. The data were presented here today at the Annual Scientific Sessions of the American Heart Association.
An observational study of more than 64,000 asthma patients demonstrated that patients receiving treatment with Advair Diskus (fluticasone propionate and salmeterol inhalation powder) had a significant risk reduction in emergency department visits due to asthma versus patients treated with fluticasone propionate (FP) alone.
Results of a new survey conducted among more than 1,000 Americans age 45 and older reveal that most adults are not concerned about Chronic Obstructive Pulmonary Disease (COPD), a lung disease that is the fourth leading cause of death in the U.S. According to the survey, only 1 in 10 adults could correctly identify what COPD is, and only 4 percent consider COPD to be a health condition they worry ?the most? about getting, compared against other common chronic diseases, such as Alzheimer?s disease, heart disease, diabetes, or lung cancer. However, more people die from COPD than breast cancer or prostate cancer each year.
Novartis announced today a positive opinion supporting European Union approval of Exforge? (valsartan/ amlodipine besylate) as a new treatment option for patients with high blood pressure.
The U. S. Food and Drug Administration (FDA) today expanded the approved use of Herceptin, a biological cancer drug. The new indication is for Herceptin, in combination with other cancer drugs, for the treatment of HER2 positive breast cancer after surgery (lumpectomy or mastectomy). FDA granted priority review to the supplemental application for Herceptin.
Adolescent girls who live within half a mile of a public park are significantly more physically active than other girls, University of North Carolina at Chapel Hill researchers have found.
Following two studies of patients who were treated with cardiac stents, physicians at Rhode Island Hospital continue to recommend drug-eluting stents (DES) as a safe and effective treatment.
REGENERX BIOPHARMACEUTICALS, INC. (AMEX: RGN) reported today that a study published in the advanced online edition of the journal Nature supported and elaborated TB4’s significant effects in the damaged hearts of mice and highlighted its therapeutic potential for the treatment of heart attacks and heart failure in humans.
A new study shows that blood flow to the legs is relatively normal in people with diastolic heart failure, suggesting other potential causes of their inability to do everyday activities, according to researchers at Wake Forest University Baptist Medical Center.